1. Home
  2. TNL vs RYTM Comparison

TNL vs RYTM Comparison

Compare TNL & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNL
    SELLHOLDBUYas of 2 days ago
  • RYTM
    SELLHOLDBUYas of 2 days ago
  • Stock Information
  • Founded
  • TNL 1990
  • RYTM 2008
  • Country
  • TNL United States
  • RYTM United States
  • Employees
  • TNL N/A
  • RYTM N/A
  • Industry
  • TNL Hotels/Resorts
  • RYTM Biotechnology: Pharmaceutical Preparations
  • Sector
  • TNL Consumer Discretionary
  • RYTM Health Care
  • Exchange
  • TNL Nasdaq
  • RYTM Nasdaq
  • Market Cap
  • TNL 3.8B
  • RYTM 3.1B
  • IPO Year
  • TNL N/A
  • RYTM 2017
  • Fundamental
  • Price
  • TNL $50.63
  • RYTM $56.12
  • Analyst Decision
  • TNL Buy
  • RYTM Strong Buy
  • Analyst Count
  • TNL 10
  • RYTM 10
  • Target Price
  • TNL $58.50
  • RYTM $65.80
  • AVG Volume (30 Days)
  • TNL 594.8K
  • RYTM 552.7K
  • Earning Date
  • TNL 02-19-2025
  • RYTM 11-05-2024
  • Dividend Yield
  • TNL 3.95%
  • RYTM N/A
  • EPS Growth
  • TNL 26.59
  • RYTM N/A
  • EPS
  • TNL 5.89
  • RYTM N/A
  • Revenue
  • TNL $3,829,000,000.00
  • RYTM $112,530,000.00
  • Revenue This Year
  • TNL $3.73
  • RYTM $63.64
  • Revenue Next Year
  • TNL $4.45
  • RYTM $42.98
  • P/E Ratio
  • TNL $9.32
  • RYTM N/A
  • Revenue Growth
  • TNL 3.12
  • RYTM 81.55
  • 52 Week Low
  • TNL $37.99
  • RYTM $35.17
  • 52 Week High
  • TNL $56.91
  • RYTM $68.58
  • Technical
  • Relative Strength Index (RSI)
  • TNL 36.87
  • RYTM 46.95
  • Support Level
  • TNL $49.90
  • RYTM $53.39
  • Resistance Level
  • TNL $53.67
  • RYTM $57.27
  • Average True Range (ATR)
  • TNL 1.11
  • RYTM 2.32
  • MACD
  • TNL -0.70
  • RYTM -0.55
  • Stochastic Oscillator
  • TNL 11.45
  • RYTM 33.21

Stock Price Comparison Chart: TNL vs RYTM

TNL
RYTM
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober0510152025303540455055606570TNL VS RYTM

About TNL Travel Leisure Co. Common Stock

Travel+Leisure Co is a membership and leisure travel company. It provides hospitality services and travel products. The company operates in the segments of Vacation Ownership, which is the key revenue-driving segment, develops, markets and sells vacation ownership interests (VOIs) to individual consumers, provides consumer financing in connection with the sale of VOIs, and provides property management services at resorts and Travel and Membership which operates a variety of travel businesses, including three vacation exchange brands, a home exchange network, travel technology platforms, travel memberships, and direct-to-consumer rentals. The majority of the revenue is earned from the United States.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in development and commercialization of therapies for patients with rare diseases. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies. Geographically the company generates its revenue from the United states, Germany, and other with the majority being generated from the United states.

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use